NCT01794845 : Clinical Trial Detail - Cancer Knowledgebase (CKB)

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT01794845
Title	Phase II Trial Using Erbitux+ Taxotere With Low Dose Fractionated Radiation for Recurrent Unresectable Locally Advanced Head and Neck Carcinoma
Recruitment	Terminated
Gender	both
Phase	Phase II
Variant Requirements	No
Sponsors	University of Miami
Indications	head and neck squamous cell carcinoma
Therapies	Cetuximab + Docetaxel
Age Groups:	adult
Covered Countries	USA

Filter rows:

Showing 1 to 1 of 1 entries

Facility	Status	City	State	Zip	Country	Details
University of Miami		Miami	Florida	33136	United States	Details

Showing 1 to 1 of 1 entries

Filter rows:

*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field

NCT01794845Clinical Trial Detail